CELEX: C2001/108/39
Language: en
Date: 2001-04-07 00:00:00
Title: Order of the President of the Court of First Instance of 31 October 2000 in Case T-83/00 R-II: Schuck GmbH v Commission of the European Communities (Proceedings for interim relief — Withdrawal of marketing authorisation for medicinal products for human use containing norpseudoephdrine — Directive 75/319/EEC — Urgency — Need to balance interests)

7.4.2001               EN                     Official Journal of the European Communities                                        C 108/21
ORDER OF THE PRESIDENT OF THE COURT OF FIRST                             Germany, with an address for service in Luxembourg at the
                            INSTANCE                                     Chambers of Bonn and Schmidt, 7 Val Sainte-Croix, against
                                                                         the Commission of the European Communities (Agents:
                       of 31 October 2000                                H. Støvlbæk and B. Wägenbaur) — application for the
                                                                         suspension of application of the decision of the Commission
in Case T-83/00 R-I: Hänseler GmbH v Commission of the                   of 9 March 2000 concerning the withdrawal of authorisations
                    European Communities                                 for placing on the market medicinal products for human
                                                                         consumption containing in particular norpseudoephedrine
(Proceedings for interim relief — Withdrawal of marketing                (C(2000) 608) — the President of the Court of First Instance
authorisation for medicinal products for human use contain-              made an order on 31 October 2000, the operative part of
ing norpseudoephdrine — Directive 75/319/EEC — Urgency                   which is as follows:
                  — Need to balance interests)
                                                                         1.   The application to the applicants of the decision of the
                         (2001/C 108/38)                                      Commission of 9 March 2000 concerning the withdrawal of
                                                                              authorisations for placing on the market medicinal products for
                                                                              human consumption containing Clobenzorex, Fenbutrazat,
                  (Language of the case: German)                              Fenproporex, Mazindol, Mefenorex, Norpseudoephedrine,
                                                                              Phenmetrazine, Phendimetrazine and Propylhexedrine
In Case T-83/00 R-I: Hänseler GmbH, established in Konstanz                   (C(2000) 608) is suspended.
(Germany), represented by B. Sträter, Rechtsanwalt, Bonn,
Germany, with an address for service in Luxembourg at the                2.   Costs are reserved.
Chambers of Bonn and Schmidt, 7 Val Sainte-Croix, against
the Commission of the European Communities (Agents:
H. Støvlbæk and B. Wägenbaur) — application for the
suspension of application of the decision of the Commission
of 9 March 2000 concerning the withdrawal of authorisations
for placing on the market medicinal products for human                   ORDER OF THE PRESIDENT OF THE COURT OF FIRST
consumption containing in particular norpseudoephedrine                                              INSTANCE
(C(2000) 608) — the President of the Court of First Instance
made an order on 31 October 2000, the operative part of                                         of 31 October 2000
which is as follows:
                                                                         in Case T-132/00 R: Gerot Pharmazeutika GmbH v the
1.   The application to the applicants of the decision of the                      Commission of European Communities
     Commission of 9 March 2000 concerning the withdrawal of
     authorisations for placing on the market medicinal products for     (Proceedings for interim relief — Withdrawal of marketing
     human consumption containing Clobenzorex, Fenbutrazat,              authorisation for medicinal products for human use contain-
     Fenproporex, Mazindol, Mefenorex, Norpseudoephedrine,               ing phentermine — Directive 75/319/EEC — Urgency —
     Phenmetrazine, Phendimetrazine and Propylhexedrine                                      Need to balance interests)
     (C(2000) 608) is suspended.
2.   Costs are reserved.                                                                          (2001/C 108/40)
                                                                                           (Language of the case: German)
                                                                         In Case T-132/00 R: Gerot Pharmazeutika GmbH, established
                                                                         in Vienna, represented by B. Sträter, Rechtsanwalt, Bonn,
ORDER OF THE PRESIDENT OF THE COURT OF FIRST                             Germany, with an address for service in Luxembourg at the
                            INSTANCE                                     Chambers of Bonn and Schmidt, 7 Val Sainte-Croix, against
                                                                         the Commission of the European Communities (Agents:
                       of 31 October 2000                                H. Støvlbæk and B. Wägenbaur) — application for the
                                                                         suspension of application of the decision of the Commission
in Case T-83/00 R-II: Schuck GmbH v Commission of the                    of 9 March 2000 concerning the withdrawal of authorisations
                    European Communities                                 for placing on the market medicinal products for human
                                                                         consumption containing phentermine (C(2000) 452) — the
(Proceedings for interim relief — Withdrawal of marketing                President of the Court of First Instance made an order on
authorisation for medicinal products for human use contain-              31 October 2000, the operative part of which is as follows:
ing norpseudoephdrine — Directive 75/319/EEC — Urgency
                  — Need to balance interests)                           1.   The application to the applicants of the decision of the
                                                                              Commission of 9 March 2000 concerning the withdrawal of
                         (2001/C 108/39)                                      authorisations for placing on the market medicinal products
                                                                              for human consumption containing the following substance:
                                                                              phentermine (C(2000) 452) is suspended.
                  (Language of the case: German)
                                                                         2.   Costs are reserved.
In Case T-83/00 R-II: Schuck GmbH, established in Schwaig
(Germany), represented by B. Sträter, Rechtsanwalt, Bonn,